Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
- Unaudited consolidated financial statements of the Krka Group and the Krka company for 2023.pdfUnaudited consolidated financial statements of the Krka Group and uaudited financial statements of the Krka company for 2023
- Press Release.pdfPress Release
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 12 | / | 2023 | ||||||||
| Date of issue: | 2024-03-14 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka, d. d., Novo mesto for 2023 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 17. 1 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on Article 26 of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto publishes 2023 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka d. d., Novo mesto with relavant notes. The report will be published on the Company's website (www.krka.biz) from 14 March 2024 onwards, for a period of at least 5 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Unaudited consolidated financial statements of the Krka Group and the Krka company for 2023.pdf Unaudited consolidated financial statements of the Krka Group and the Krka company for 2023.pdf | Unaudited consolidated financial statements of the Krka Group and uaudited financial statements of the Krka company for 2023 | ||||||||||
| Press Release.pdf Press Release.pdf | Press Release | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2024-03-14 | Jože Colarič | President of the Management Board and CEO | |||
20240314_082444_1009688997_Press_Release.pdf
20240314_082444_1009688997_Unaudited_consolidated_financial_statements_of_the_Krka_Group_and_the_Krka_company_for_2023.pdf
